Federated Hermes’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-85
| Closed | -$1.14K | – | 2188 |
|
|
2023
Q4 | $1.14K | Sell |
85
-3
| -3% | -$38 | ﹤0.01% | 1970 |
|
|
2023
Q3 | $1.08K | Sell |
88
-2
| -2% | -$24 | ﹤0.01% | 2005 |
|
|
2023
Q2 | $1.11K | Hold |
90
| – | – | ﹤0.01% | 2024 |
|
|
2023
Q1 | $1.11K | Hold |
90
| – | – | ﹤0.01% | 2041 |
|
|
2022
Q4 | $1.03K | Sell |
90
-1
| -1% | -$8 | ﹤0.01% | 2053 |
|
|
2022
Q3 | $1K | Hold |
91
| – | – | ﹤0.01% | 2130 |
|
|
2022
Q2 | $1K | Hold |
91
| – | – | ﹤0.01% | 2125 |
|
|
2022
Q1 | $1K | Hold |
91
| – | – | ﹤0.01% | 2165 |
|
|
2021
Q4 | $1K | Sell |
91
-129
| -59% | -$560 | ﹤0.01% | 2193 |
|
|
2021
Q3 | $1K | Hold |
220
| – | – | ﹤0.01% | 2195 |
|
|
2021
Q2 | $1K | Sell |
220
-2
| -0.9% | -$13 | ﹤0.01% | 2186 |
|
|
2021
Q1 | $1K | Hold |
222
| – | – | ﹤0.01% | 2206 |
|
|
2020
Q4 | $2K | Sell |
222
-111
| -33% | -$547 | ﹤0.01% | 2150 |
|
|
2020
Q3 | $1K | Sell |
333
-59
| -15% | -$217 | ﹤0.01% | 2237 |
|
|
2020
Q2 | $1K | Sell |
392
-635
| -62% | -$2.17K | ﹤0.01% | 2222 |
|
|
2020
Q1 | $2K | Sell |
1,027
-805
| -44% | -$2.35K | ﹤0.01% | 2059 |
|
|
2019
Q4 | $6K | Hold |
1,832
| – | – | ﹤0.01% | 1953 |
|
|
2019
Q3 | $8K | Sell |
1,832
-1,545
| -46% | -$7.72K | ﹤0.01% | 1915 |
|
|
2019
Q2 | $16K | Sell |
3,377
-7,443
| -69% | -$35.3K | ﹤0.01% | 1841 |
|
|
2019
Q1 | $59K | Sell |
10,820
-50,599
| -82% | -$233K | ﹤0.01% | 1640 |
|
|
2018
Q4 | $187K | Sell |
61,419
-488
| -0.8% | -$1.69K | ﹤0.01% | 1564 |
|
|
2018
Q3 | $260K | Sell |
61,907
-51,898
| -46% | -$219K | ﹤0.01% | 1571 |
|
|
2018
Q2 | $440K | Sell |
113,805
-24,962
| -18% | -$166K | ﹤0.01% | 1434 |
|
|
2018
Q1 | $879K | Sell |
138,767
-10,842
| -7% | -$89.7K | ﹤0.01% | 1268 |
|
|
2017
Q4 | $1.21M | Buy |
+149,609
| New | +$1.39M | ﹤0.01% | 1154 |
|
|
2016
Q4 | – | Sell |
-12,710
| Closed | -$635K | – | 2235 |
|
|
2016
Q3 | $635K | Buy |
12,710
+2,542
| +25% | +$106K | ﹤0.01% | 1217 |
|
|
2016
Q2 | $431K | Hold |
10,168
| – | – | ﹤0.01% | 1317 |
|
|
2016
Q1 | $670K | Sell |
10,168
-835
| -8% | -$43.6K | ﹤0.01% | 1200 |
|
|
2015
Q4 | $684K | Buy |
11,003
+3,377
| +44% | +$238K | ﹤0.01% | 1203 |
|
|
2015
Q3 | $511K | Sell |
7,626
-11,740
| -61% | -$958K | ﹤0.01% | 1278 |
|
|
2015
Q2 | $1.88M | Buy |
19,366
+11,308
| +140% | +$1.08M | 0.01% | 943 |
|
|
2015
Q1 | $753K | Buy |
8,058
+2,974
| +58% | +$253K | ﹤0.01% | 1261 |
|
|
2014
Q4 | $452K | Sell |
5,084
-5,084
| -50% | -$370K | ﹤0.01% | 1374 |
|
|
2014
Q3 | $702K | Hold |
10,168
| – | – | ﹤0.01% | 1274 |
|
|
2014
Q2 | $583K | Buy |
+10,168
| New | +$516K | ﹤0.01% | 1317 |
|
Other funds holding MACK
WSL
NM
ACM
MAP
SC
Federated Hermes's MACK Position: Q1 2024 in Review
Federated Hermes sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2024, closing a stake of 85 shares — an estimated $1.14K sold.
Federated Hermes first reported a position in MACK in Q2 2014 and held it in 35 quarters. The position peaked at $1.88M in Q2 2015. 70 funds tracked by Wall St. Rank hold MACK as of Q1 2024.
- Federated Hermes reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
- Federated Hermes sold 85 Merrimack Pharmaceuticals, Inc. shares in Q1 2024, an estimated $1.14K.
- Federated Hermes first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2014 and held it in 35 quarters.
- Federated Hermes's Merrimack Pharmaceuticals, Inc. position peaked at $1.88M in Q2 2015.
- 70 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2024.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.